Research looks at factors linked to chronic pain | Sodium levels may affect headaches, study finds | Scintilla boosts pain management pipeline with Semnur purchase
August 17, 2016
News for the pain professional
Pain Research News
Research looks at factors linked to chronic pain
A study in PLOS Medicine that included 100,000 people suggests chronic pain may be linked partly to genetics and partly to risk factors shared by partners or spouses. Researchers said chronic pain and depression may have common causes associated with genetic and shared environments.
HealthDay News (8/16) 
LinkedIn Twitter Facebook Google+ Email
Sodium levels may affect headaches, study finds
Dietary data on 8,819 adults found those with the highest sodium levels had the fewest severe headaches and migraines, according to a study in the journal Headache. Researcher Michael Harrington at Huntington Medical Research Institutes said people who experience migraines might handle sodium differently because generally high sodium levels tend to make neurons more excitable.
New Scientist (free content) (8/15) 
LinkedIn Twitter Facebook Google+ Email
Other News
Treatment News
Study: rTMS treatments may reduce phantom limb pain
Two weeks of transcranial magnetic stimulation led to a significant reduction in phantom limb pain for 70% of amputees, according to a study in the Journal of Pain. The placebo-controlled study included 54 patients who had amputations due to land mines.
Healio (free registration)/O&P News (8/15) 
LinkedIn Twitter Facebook Google+ Email
Older surgical patients at low risk for chronic opioid use, study finds
A Canadian study in the journal JAMA Surgery found that patients aged 65 or older had a very low risk of long-term opioid use after surgery. The findings, based on data for more than 39,000 opioid-naive patients who underwent surgery, found that 53% received at least one opioid prescription within 90 days after hospital discharge, and only 0.4% were still receiving opioid prescriptions a year after surgery.
HealthDay News (8/10),  United Press International (8/10) 
LinkedIn Twitter Facebook Google+ Email
Other News
Policy & Trends
Endo takes back sNDA application for opioid painkiller
Endo's supplemental new drug application to get its extended-release opioid painkiller Opana labeled as abuse deterrent has been withdrawn by the firm after a discussion with representatives from the FDA. The firm plans to continue its epidemiological research into abuse deterrence and could refile for an NDA at an unspecified time in the future.
The Wall Street Journal (tiered subscription model) (8/12),  Genetic Engineering & Biotechnology News (8/12) 
LinkedIn Twitter Facebook Google+ Email
Hospitalists discuss how to balance pain relief, overdose risk
Hospitalists who provide pain management reported in interviews that they struggle to balance relief of chronic pain with calls to reduce prescriptions of opioid drugs, according to a study in the Journal of Hospital Medicine. Hospitalists said they were confident about using opioid medications to reduce acute pain but less so about prescribing them to hospitalized patients with chronic pain.
Medscape (free registration) (8/12) 
LinkedIn Twitter Facebook Google+ Email
APS News
Call for poster abstracts -- now open!
The APS Scientific Program Committee (SPC) invites you to submit a poster abstract and present to hundreds of pain professionals at the 2017 Annual Scientific Meeting in Pittsburgh. The SPC is seeking original research that has not been previously presented or published elsewhere, prior to the APS meeting. All accepted posters will be presented at the 2017 Annual Scientific Meeting, May 17-20, 2017, and will be published in a supplement to The Journal of Pain. Learn more.
LinkedIn Twitter Facebook Google+ Email
Check it out -- APS News
Have you visited the APS website lately? Take a look at the APS News section on the homepage for timely updates about the Society and the field. Learn the latest on APS events and activities and other valuable information With regular updates, this makes it easy for you to stay involved in pain related news regarding research, education, treatment and advocacy. Learn more.
LinkedIn Twitter Facebook Google+ Email
A lot of people are afraid to say what they want. That's why they don't get what they want.
LinkedIn Twitter Facebook Google+ Email
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information